Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Lebwohl

Showing results (221-230 of 418) with videos related to

Pageof 42
Sort By:
Photomedicine and Laser Surgery|August 1, 2006
Treatment of vitiligo using the 308-nm excimer laserSuhail Hadi, Patricia Tinio, Khalid Al-Ghaithi, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
One-Year Pharmacovigilance Update of BrodalumabMark Lebwohl, Craig Leonardi, Jashin J Wu, et al.
American Journal of Clinical Dermatology|February 26, 2017
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
The American Journal of the Medical Sciences|February 11, 2004
Frequency of culture-proven dermatophyte infection in patients with suspected tinea pedisAaron Fuchs, Jodi Fiedler, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|March 19, 2011
In response to "Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity?"Amylynne Frankel, Abby S Van Voorhees, Sylvia Hsu, et al.
Carcinogenesis|March 9, 2006
Photoprotective effect of isoflavone genistein on ultraviolet B-induced pyrimidine dimer formation and PCNA expression in human reconstituted skin and its implications in dermatology and prevention of cutaneous carcinogenesisJulian O Moore, Yongyin Wang, William G Stebbins, et al.
American Journal of Clinical Dermatology|May 26, 2017
Erratum to: Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
The Journal of Clinical and Aesthetic Dermatology|May 23, 2018
Early Onset of Clinical Improvement with Ixekizumab in a Randomized, Open-label Study of Patients with Moderate-to-severe Plaque PsoriasisSaakshi Khattri, Orin Goldblum, Kathleen Solotkin, et al.
The Journal of Dermatological Treatment|December 5, 2025
Laboratory monitoring in patients with moderate to severe plaque psoriasisJonathan M Fenkel, John A Osborne, April W Armstrong, et al.
Journal of the American Academy of Dermatology|July 6, 2010
Pilot, multicenter, double-blind, randomized placebo-controlled bilateral comparative study of a combination of calcipotriene and nicotinamide for the treatment of psoriasisDanielle Levine, Zeev Even-Chen, Irina Lipets, et al.
Pageof 42

Showing results (221-230 of 418) with videos related to

Sort By:
Pageof 42
Photomedicine and Laser Surgery|August 1, 2006
Treatment of vitiligo using the 308-nm excimer laserSuhail Hadi, Patricia Tinio, Khalid Al-Ghaithi, et al.
Journal of Drugs in Dermatology : JDD|August 27, 2020
One-Year Pharmacovigilance Update of BrodalumabMark Lebwohl, Craig Leonardi, Jashin J Wu, et al.
American Journal of Clinical Dermatology|February 26, 2017
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
The American Journal of the Medical Sciences|February 11, 2004
Frequency of culture-proven dermatophyte infection in patients with suspected tinea pedisAaron Fuchs, Jodi Fiedler, Mark Lebwohl, et al.
Journal of the American Academy of Dermatology|March 19, 2011
In response to "Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity?"Amylynne Frankel, Abby S Van Voorhees, Sylvia Hsu, et al.
Carcinogenesis|March 9, 2006
Photoprotective effect of isoflavone genistein on ultraviolet B-induced pyrimidine dimer formation and PCNA expression in human reconstituted skin and its implications in dermatology and prevention of cutaneous carcinogenesisJulian O Moore, Yongyin Wang, William G Stebbins, et al.
American Journal of Clinical Dermatology|May 26, 2017
Erratum to: Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE StudyCarle Paul, Craig Leonardi, Alan Menter, et al.
The Journal of Clinical and Aesthetic Dermatology|May 23, 2018
Early Onset of Clinical Improvement with Ixekizumab in a Randomized, Open-label Study of Patients with Moderate-to-severe Plaque PsoriasisSaakshi Khattri, Orin Goldblum, Kathleen Solotkin, et al.
The Journal of Dermatological Treatment|December 5, 2025
Laboratory monitoring in patients with moderate to severe plaque psoriasisJonathan M Fenkel, John A Osborne, April W Armstrong, et al.
Journal of the American Academy of Dermatology|July 6, 2010
Pilot, multicenter, double-blind, randomized placebo-controlled bilateral comparative study of a combination of calcipotriene and nicotinamide for the treatment of psoriasisDanielle Levine, Zeev Even-Chen, Irina Lipets, et al.
Pageof 42